More than 50 Pharmaceutical companies focusing on innovative Antibody based cancer treatment.
December 5 2003--Research and Markets announces the addition of this new report entitles "Antibodies as Cancer Therapeutics - R&D & Business Perspectives" to its offerings.
In September 2003 the Roche subsidiary Genentech completed its US filing for approval to market the monoclonal antibody therapeutic Avastin as a treatment for colorectal cancer. Approval is expected by the end of the first quarter of 2004 and the blockbuster status expected for this therapy may change the way that industry looks upon antibody treatment of cancer in general.
Antibody therapy is a proven breakthrough for cancer treatment. This 300-page report is a close to complete description of ongoing development in the field of innovative antibody strategies for the treatment of cancer. "Antibodies as Cancer Therapeutics - R&D Situation & Business Perspectives -" analyzes more than 300 industry related R&D projects evaluating antibody based cancer therapies. The report identifies trends and also describes and analyzes strategic shifts made by the industry.
There are more than 50 companies focused on developing antibody based cancer treatments. With several approved monoclonal antibodies for at least 5 cancer indications and no less than 9 companies with projects that have reached phase III trials this field has evolved into a reality for cancer patients. The aim of this report is to analyze changes and progress in how antibodies are used for trying to treat cancer as well as describe the current and future business climate.
For a complete index of this report click on http://www.researchandmarkets.com/reports/41614
About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.
For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com
This article courtesy of http://www.seecancer.com.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.